Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
CrossRef.
Andrew, Eisen
Heather, Stewart
Michael, Schulzer
and
Donald, Cameron
1993.
Anti-Glutamate Therapy in Amyotrophic Lateral Sclerosis: A Trial Using Lamotrigine.
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques,
Vol. 20,
Issue. 4,
p.
297.
Mano, Yukio
Morita, Yuuji
Tamura, Ryuji
Morimoto, Shigeru
Takayanagi, Tetsuya
and
Mayer, Richard F
1993.
The site of action of magnetic stimulation of human motor cortex in a patient with motor neuron disease.
Journal of Electromyography and Kinesiology,
Vol. 3,
Issue. 4,
p.
245.
1993.
Platform Presentations.
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques,
Vol. 20,
Issue. 4,
p.
343.
Prout, Alister J.
and
Eisen, Andrew A.
1994.
The cortical silent period and amyotrophic lateral sclerosis.
Muscle & Nerve,
Vol. 17,
Issue. 2,
p.
217.
Rowland, Lewis P.
1994.
Riluzole for the Treatment of Amyotrophic Lateral Sclerosis -- Too Soon to Tell?.
New England Journal of Medicine,
Vol. 330,
Issue. 9,
p.
636.
Schiffer, D.
Attanasio, A.
Chiò, A.
Migheli, A.
and
Pezzulo, T.
1994.
Ubiquitinated dystrophic neurites suggest corticospinal derangement in patients with amyotrophic lateral sclerosis.
Neuroscience Letters,
Vol. 180,
Issue. 1,
p.
21.
Mortifee, Peter
Stewart, Heather
Schulzer, Michael
and
Eisen, Andrew
1994.
Reliability of transcranial magnetic stimulation for mapping the human motor cortex.
Electroencephalography and Clinical Neurophysiology/Evoked Potentials Section,
Vol. 93,
Issue. 2,
p.
131.
Moos, Torben
1995.
Age-dependent uptake and retrograde axonal transport of exogenous albumin and transferrin in rat motor neurons.
Brain Research,
Vol. 672,
Issue. 1-2,
p.
14.
Aguilera, Arnold J.
1995.
Molecular Genetic Advances in Neurodegenerative Disorders.
Clinics in Laboratory Medicine,
Vol. 15,
Issue. 4,
p.
915.
Thomas, Robert Joseph
1995.
Exitatory Amino Acids in Health and Disease.
Journal of the American Geriatrics Society,
Vol. 43,
Issue. 11,
p.
1279.
Vickers, James C.
Huntley, George W.
and
Morrison, John H.
1995.
Neurotransmitters in the Human Brain.
Vol. 43,
Issue. ,
p.
79.
Eisen, Andrew
1995.
Amyotrophic lateral sclerosis is a multifactorial disease.
Muscle & Nerve,
Vol. 18,
Issue. 7,
p.
741.
Schiffer, Davide
Cordera, Susanna
Giordana, Maria Teresa
Attanasio, Angelo
and
Pezzulo, Tiziana
1995.
Synaptic vesicle proteins, synaptophysin and chromogranin A in amyotrophic lateral sclerosis.
Journal of the Neurological Sciences,
Vol. 129,
Issue. ,
p.
68.
Claus, D.
Brunhölzl, C.
Kerling, F.P.
and
Henschel, S.
1995.
Transcranial magnetic stimulation as a diagnostic and prognostic test in amyotrophic lateral sclerosis.
Journal of the Neurological Sciences,
Vol. 129,
Issue. ,
p.
30.
Messenheimer, John A.
1995.
Lamotrigine.
CNS Drug Reviews,
Vol. 1,
Issue. 2,
p.
190.
Awiszus, Friedemann
and
Feistner, Helmut
1995.
Comparison of single motor unit responses to transcranial magnetic and peroneal nerve stimulation in the tibialis anterior muscle of patients with amyotrophic lateral sclerosis.
Electroencephalography and Clinical Neurophysiology/Electromyography and Motor Control,
Vol. 97,
Issue. 2,
p.
90.
Cabot, Richard C.
Scully, Robert E.
Mark, Eugene J.
McNeely, William F.
McNeely, Betty U.
Triggs, W.J.
and
Edgar, M.A.
1995.
Case 36-1995.
New England Journal of Medicine,
Vol. 333,
Issue. 21,
p.
1406.
Kohara, N.
Kaji, R.
Kojima, Y.
Mills, K.R.
Fujii, H.
Hamano, T.
Kimura, J.
Takamatsu, N.
and
Uchiyama, T.
1996.
Abnormal excitability of the corticospinal pathway in patients with amyotrophic lateral sclerosis: a single motor unit study using transcranial magnetic stimulation.
Electroencephalography and Clinical Neurophysiology/Electromyography and Motor Control,
Vol. 101,
Issue. 1,
p.
32.
Brooks, Benjamin Rix
1996.
CLINICAL EPIDEMIOLOGY OF AMYOTROPHIC LATERAL SCLEROSIS.
Neurologic Clinics,
Vol. 14,
Issue. 2,
p.
399.
Williams, T. L.
Day, N. C.
Ince, P. G.
Kamboj, R. K.
and
Shaw, P. J.
1997.
Calcium-permeable ?-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors: A molecular determinant of selective vulnerability in amyotrophic lateral sclerosis.
Annals of Neurology,
Vol. 42,
Issue. 2,
p.
200.